Kurt Lang
Impact in
- Immunology top 5%
- Toxin Mechanisms and Immunotoxins
- Molecular Biology top 5%
- Signaling Pathways in Disease
- Metabolism, Diabetes, and Cancer
- Protein Structure and Dynamics
Papers in
-
- Metabolism, Diabetes, and Cancer 5
- Protein Structure and Dynamics 4
- Signaling Pathways in Disease 4
- RNA and protein synthesis mechanisms 2
-
- Growth Hormone and Insulin-like Growth Factors 5
- Co-authors
- Brigitte Wittmann‐Liebold (1 shared paper)Franz X. Schmid (1 shared paper)Günter Fischer (1 shared paper)Thomas Kiefhaber (1 shared paper)Franz X. Schmid (7 shared papers)Gunter Fischer (2 shared papers)Carola Dony (2 shared papers)Tad A. Holak (5 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)Nature (3 papers)The EMBO Journal (2 papers)Journal of Molecular Biology (2 papers)Pharmaceutical Research (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Kurt Lang
19 papers receiving 2.6k citations
Kurt Lang's Hit Papers
Peers
Comparison fields: 5 of 99
- Immunology 678
- Molecular Biology 2.1k
- Endocrinology, Diabetes and Metabolism 448
- Oncology 586
- Cancer Research 202
Countries citing papers authored by Kurt Lang
This map shows the geographic impact of Kurt Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Lang more than expected).
Fields of papers citing papers by Kurt Lang
This network shows the impact of papers produced by Kurt Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Lang. The network helps show where Kurt Lang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kurt Lang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins Hit paper breakdown → | 1989 | 1191 |
| 2 | 1987 | 390 | |
| 3 | 1995 | 261 | |
| 4 | 1998 | 151 | |
| 5 | 1997 | 107 | |
| 6 | 2001 | 92 | |
| 7 | 1988 | 86 | |
| 8 | 2001 | 76 | |
| 9 | 2005 | 65 | |
| 10 | 1993 | 61 | |
| 11 | 1998 | 38 | |
| 12 | 2013 | 24 | |
| 13 | 1986 | 23 | |
| 14 | 1990 | 19 | |
| 15 | 2002 | 18 | |
| 16 | 1996 | 18 | |
| 17 | 1986 | 18 | |
| 18 | 1986 | 17 | |
| 19 | 2002 | 7 |
About Kurt Lang
Kurt Lang is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Oncology, Genetics and Immunology, having authored 19 papers that have together received 2.7k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (5 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Protein Structure and Dynamics (4 papers), Signaling Pathways in Disease (4 papers), Enzyme Structure and Function (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Transgenic Plants and Applications (2 papers) and RNA and protein synthesis mechanisms (2 papers). The work is most often cited by research in Immunology (678 citations), Molecular Biology (2.1k citations), Endocrinology, Diabetes and Metabolism (448 citations), Oncology (586 citations) and Cancer Research (202 citations). Kurt Lang has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Brigitte Wittmann‐Liebold, Franz X. Schmid, Günter Fischer, Thomas Kiefhaber, Franz X. Schmid, Gunter Fischer, Carola Dony, Tad A. Holak, Ulrike Leser and Yoko Honda. Their work appears in journals such as Journal of Biological Chemistry, Nature, The EMBO Journal, Journal of Molecular Biology and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.